Vaccine Manufacturers

COVID-19 Vaccination and Uveitis Relapse

Scientists analyzed a group of 438 participants with a history of uveitis who received at least one dose of the COVID-19 vaccine but had no history of previous COVID-19 infection. Participants received one of the vaccines available in China, including Sinovac, Sinopharm, CanSino, and Zhifei.

Read More »

SLE Flares Post COVID-19 Vaccine

A study in Japan analyzed the association between mRNA Covid-19 vaccination and medium-term SLE flare-ups. At 30 days after completion of a primary series, the rate of mild or moderate SLE flares was 20.3% within the vaccinated group, versus 23.3% in the unvaccinated group. Flare rates at 60 and 90 days were similar between both groups. 

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.